Skip to main navigation Skip to search Skip to main content

Phase II study of the tetrahydropyranyl adriamycin-cyclophosphamide, vincristine, and prednisolone regimen combined with rituximab as first-line treatment for elderly patients with diffuse large B-cell lymphoma

  • Senji Kasahara
  • , Takeshi Hara
  • , Hisashi Tsurumi
  • , Naoe Goto
  • , Jun Ichi Kitagawa
  • , Nobuhiro Kanemura
  • , Takeshi Yoshikawa
  • , Hideko Goto
  • , Kenji Fukuno
  • , Toshiki Yamada
  • , Michio Sawada
  • , Takeshi Takahashi
  • , Tsuyoshi Takami
  • , Hisataka Moriwaki

Research output: Contribution to journal › Article › peer-review

25   Link opens in a new tab Citations (Scopus)

Fingerprint

Dive into the research topics of 'Phase II study of the tetrahydropyranyl adriamycin-cyclophosphamide, vincristine, and prednisolone regimen combined with rituximab as first-line treatment for elderly patients with diffuse large B-cell lymphoma'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science